Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2009. Start Trial.
Date Value
October 23, 2026 1.401
October 22, 2026 1.414
October 21, 2026 1.380
October 20, 2026 1.395
October 19, 2026 1.333
October 16, 2026 1.368
October 15, 2026 1.357
October 14, 2026 1.340
October 13, 2026 1.318
October 12, 2026 1.339
October 09, 2026 1.350
October 08, 2026 1.355
October 07, 2026 1.354
October 06, 2026 1.333
October 05, 2026 1.331
October 02, 2026 1.345
October 01, 2026 1.370
September 30, 2026 1.389
September 29, 2026 1.372
September 28, 2026 1.387
September 25, 2026 1.385
September 24, 2026 1.379
September 23, 2026 1.403
September 22, 2026 1.432
September 21, 2026 1.432
Date Value
September 18, 2026 1.431
September 17, 2026 1.453
September 16, 2026 1.435
September 15, 2026 1.428
September 14, 2026 1.460
September 11, 2026 1.441
September 10, 2026 1.439
September 09, 2026 1.444
September 08, 2026 1.454
September 04, 2026 1.490
September 03, 2026 1.493
September 02, 2026 1.498
September 01, 2026 1.495
August 31, 2026 1.494
August 28, 2026 1.510
August 27, 2026 1.510
August 26, 2026 1.530
August 25, 2026 1.550
August 24, 2026 1.539
August 21, 2026 1.545
August 20, 2026 1.521
August 19, 2026 1.544
August 18, 2026 1.515
August 17, 2026 1.496
August 14, 2026 1.473

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
AstraZeneca PLC 11.24
GSK Plc 4.383
Johnson & Johnson 7.789
Eli Lilly & Co. 35.39
Merck & Co., Inc. 8.552

Price to Book Value Related Metrics